BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34936469)

  • 1. Toward an Optimized Staging System for Pancreatic Ductal Adenocarcinoma: A Clinically Interpretable, Artificial Intelligence-Based Model.
    Bertsimas D; Margonis GA; Huang Y; Andreatos N; Wiberg H; Ma Y; Mcintyre C; Pulvirenti A; Wagner D; van Dam JL; Gavazzi F; Buettner S; Imai K; Stasinos G; He J; Kamphues C; Beyer K; Seeliger H; Weiss MJ; Kreis M; Cameron JL; Wei AC; Kornprat P; Baba H; Koerkamp BG; Zerbi A; D'Angelica M; Wolfgang CL
    JCO Clin Cancer Inform; 2021 Dec; 5():1220-1231. PubMed ID: 34936469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Number of Positive Lymph Nodes Is Superior to LNR and LODDS for Predicting the Prognosis of Pancreatic Neuroendocrine Neoplasms.
    Gao B; Zhou D; Qian X; Jiang Y; Liu Z; Zhang W; Wang W
    Front Endocrinol (Lausanne); 2021; 12():613755. PubMed ID: 33746899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proposal of a modified American Joint Committee on Cancer staging scheme for resectable pancreatic ductal adenocarcinoma with a lymph node ratio-based N classification: A retrospective cohort study.
    Li HJ; Chen YT; Yuan SQ
    Medicine (Baltimore); 2018 Aug; 97(34):e12094. PubMed ID: 30142869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic assessment of different lymph node staging methods for pancreatic cancer with R0 resection: pN staging, lymph node ratio, log odds of positive lymph nodes.
    La Torre M; Nigri G; Petrucciani N; Cavallini M; Aurello P; Cosenza G; Balducci G; Ziparo V; Ramacciato G
    Pancreatology; 2014; 14(4):289-94. PubMed ID: 25062879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The relationship between the index of lymph node metastasis and the prognosis of pancreatic cancer patients after R0 resection].
    Ren H; Wang CF
    Zhonghua Zhong Liu Za Zhi; 2020 Jun; 42(6):474-479. PubMed ID: 32575943
    [No Abstract]   [Full Text] [Related]  

  • 6. Prognostic impact of lymph node status in patients after total pancreatectomy for pancreatic ductal adenocarcinoma: A strobe-compliant study.
    Zheng ZJ; Wang MJ; Tan CL; Chen YH; Ping J; Liu XB
    Medicine (Baltimore); 2020 Feb; 99(8):e19327. PubMed ID: 32080152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymph Node Metastatic Patterns and Survival Predictors Based on Tumor Size in Pancreatic Ductal Adenocarcinoma.
    Pu N; Chen Q; Gan W; Shen Y; Gao S; Habib JR; Yin H; Zhang J; Kinny-Köster B; Cui M; Li J; Dong Y; Nagai M; Liu L; Yu J; Wu W; Lou W
    Adv Ther; 2021 Aug; 38(8):4258-4270. PubMed ID: 34176089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of nodal statuses in patients with pancreatic ductal adenocarcinoma.
    Fukuda Y; Asaoka T; Maeda S; Hama N; Miyamoto A; Mori M; Doki Y; Nakamori S
    Pancreatology; 2017; 17(2):279-284. PubMed ID: 28122676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the lymph node ratio in pancreatic ductal adenocarcinoma. Impact on patient stratification and prognosis.
    La Torre M; Cavallini M; Ramacciato G; Cosenza G; Rossi Del Monte S; Nigri G; Ferri M; Mercantini P; Ziparo V
    J Surg Oncol; 2011 Nov; 104(6):629-33. PubMed ID: 21713779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International Validation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) TNM Staging System in Patients With Resected Pancreatic Cancer.
    van Roessel S; Kasumova GG; Verheij J; Najarian RM; Maggino L; de Pastena M; Malleo G; Marchegiani G; Salvia R; Ng SC; de Geus SW; Lof S; Giovinazzo F; van Dam JL; Kent TS; Busch OR; van Eijck CH; Koerkamp BG; Abu Hilal M; Bassi C; Tseng JF; Besselink MG
    JAMA Surg; 2018 Dec; 153(12):e183617. PubMed ID: 30285076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic lymph node ratio successfully predicts prognosis in western gastric cancer patients.
    Kutlu OC; Watchell M; Dissanaike S
    Surg Oncol; 2015 Jun; 24(2):84-8. PubMed ID: 25912951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymph node ratio versus number of affected lymph nodes as predictors of survival for resected pancreatic adenocarcinoma.
    Bhatti I; Peacock O; Awan AK; Semeraro D; Larvin M; Hall RI
    World J Surg; 2010 Apr; 34(4):768-75. PubMed ID: 20052471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of different node staging systems in patients with ≤15 lymph nodes following surgery for gastric adenocarcinoma.
    Kılıç MÖ; Gündoğdu SB; Özden S; Saylam B; Tez M
    Acta Chir Belg; 2018 Feb; 118(1):1-6. PubMed ID: 28669280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic nomograms combining N classification with ratio-based nodal classifications to predict long-term survival for patients with lung adenocarcinoma after surgery: a SEER population-based study.
    Wang S; Yu Y; Xu W; Lv X; Zhang Y; Liu M
    BMC Cancer; 2021 Aug; 21(1):653. PubMed ID: 34344326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The number and ratio of positive lymph nodes affect pancreatic cancer patient survival after neoadjuvant therapy and pancreaticoduodenectomy.
    Fischer LK; Katz MH; Lee SM; Liu L; Wang H; Varadhachary GR; Wolff RA; Lee JE; Maitra A; Roland CL; Fleming JB; Estrella J; Rashid A; Wang H
    Histopathology; 2016 Jan; 68(2):210-20. PubMed ID: 25945396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Lymph Node Ratio-Based Staging Model Is Superior to the Current Staging System for Pancreatic Neuroendocrine Tumors.
    Gaitanidis A; Patel D; Nilubol N; Tirosh A; Kebebew E
    J Clin Endocrinol Metab; 2018 Jan; 103(1):187-195. PubMed ID: 29069375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Nomogram for patients undergoing radical Pancreaticoduodenectomy for adenocarcinoma of the pancreatic head.
    Wu C; Hou SZ; Wu Z; Huang X; Wang Z; Tian B
    BMC Cancer; 2021 May; 21(1):624. PubMed ID: 34044806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An interactive Bayesian model for prediction of lymph node ratio and survival in pancreatic cancer patients.
    Smith BJ; Mezhir JJ
    J Am Med Inform Assoc; 2014 Oct; 21(e2):e203-11. PubMed ID: 24444460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic adenocarcinoma: number of positive nodes allows to distinguish several N categories.
    Strobel O; Hinz U; Gluth A; Hank T; Hackert T; Bergmann F; Werner J; Büchler MW
    Ann Surg; 2015 May; 261(5):961-9. PubMed ID: 24979603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gross tumor size using the AJCC 8th ed. T staging criteria does not provide prognostic stratification for neoadjuvant treated pancreatic ductal adenocarcinoma.
    Rowan DJ; Hartley CP; Aldakkak M; Christians KK; Evans DB; Tsai S; Hagen CE
    Ann Diagn Pathol; 2020 Jun; 46():151485. PubMed ID: 32172219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.